http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ME-00523-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_374bd30b140c412aedda14571cbbc4a7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
filingDate 2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9647957104688f813322128f09f18fae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f8f4a84034cfa9ac13ab3d9708af4db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36191f83cbe4dc866a5faff1b6c2883e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17090e6f59957f872448aaae172e7a3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff84c2fd51ff2c61635a0c2b96da749b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de9c2539db14fd642bebcb9bc0d6179e
publicationDate 2011-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ME-00523-B
titleOfInvention PHARMACEUTICAL SOLUTIONS OF LEVOSIMENDAN
abstract The present invention relates to levosimendan solutions for pharmaceutical use, and in particular for intravenous administration. The solutions of the invention have increased stability and are particularly useful as infusion or injection solutions or infusion concentrates. Levosimendan is useful in treating congestive heart attacks.
priorityDate 1999-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033825
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502430

Total number of triples: 30.